February 22, 2005
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Drug companies spent more than $38 billion on R&D
WASHINGTON — Biotechnology and pharmaceutical companies invested $38.8 billion in research and development in 2004, according to the Pharmaceutical Research and Manufacturers of America.
Of the $38.8 billion, PhRMA‘s member companies spent an estimated $30.6 billion within the United States and the rest overseas, the industry group said. Member companies spent about 18.8% of domestic sales on R&D in the United States, the group said.